Devises / BLTE
BLTE: Belite Bio Inc - American Depositary Shares
63.03
USD
1.48
(2.29%)
Le taux de change de BLTE a changé de -2.29% aujourd'hui. Au cours de la journée, l'instrument a été échangé à un minimum de 62.50 et à un maximum de 64.63.
Suivez la dynamique Belite Bio Inc - American Depositary Shares. Les cotations en temps réel vous aideront à réagir rapidement aux changements du marché. En basculant entre différentes périodes, vous pouvez surveiller les tendances et la dynamique des taux de change par minutes, heures, jours, semaines et mois. Utilisez ces informations pour prévoir les changements du marché et prendre des décisions de trading éclairées.
- M5
- M15
- M30
- H1
- H4
- D1
- W1
- MN
BLTE Nouvelles
- Belite Bio at H.C. Wainwright Conference: Strategic Focus on Eye Diseases
- Benchmark reiterates Buy rating on Belite Bio stock, maintains $80 price target
- Belite Bio, Inc 2025 Q2 - Results - Earnings Call Presentation (NASDAQ:BLTE)
- Belite Bio, Inc (BLTE) Q2 2025 Earnings Call Transcript
- Belite Bio Q2 2025 presentation: expenses rise as clinical trials advance
- Belite Bio raises $15 million in registered direct offering
- New Strong Sell Stocks for August 4th
- India blocks 25 streaming platforms over obscene content concerns
- New Strong Sell Stocks for July 22nd
- Belite Bio stock maintains Buy rating at H.C. Wainwright on trial progress
- Belite Bio at Stifel Forum: Strategic Drug Developments
- Belite Bio stock holds $80 target on FDA breakthrough nod
- Dycom Industries Posts Upbeat Earnings, Joins WeRide, Keysight Technologies And Other Big Stocks Moving Higher On Wednesday - Arcellx (NASDAQ:ACLX), Akso Health (NASDAQ:AHG)
- Belite Bio Announces FDA Granting of Breakthrough Therapy Designation for Tinlarebant for the Treatment of Stargardt Disease
- LightBio at H.C. Wainwright Conference: Telariband’s Promising Path
- Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing
- Belite Bio at Deutsche Bank Conference: Promising Drug Trials
- Benchmark maintains Buy on Belite Bio stock, $80 price target unchanged
- Belite Bio stock retains Overweight rating at Cantor Fitzgerald
- Belite Bio, Inc. (BLTE) Q4 2024 Earnings Call Transcript
- Belite Bio: The Picture Is Still Unclear (NASDAQ:BLTE)
Range quotidien
62.50
64.63
Range Annuel
43.70
86.53
- Clôture Précédente
- 64.51
- Ouverture
- 63.80
- Bid
- 63.03
- Ask
- 63.33
- Plus Bas
- 62.50
- Plus Haut
- 64.63
- Volume
- 23
- Changement quotidien
- -2.29%
- Changement Mensuel
- -1.81%
- Changement à 6 Mois
- 9.24%
- Changement Annuel
- 31.01%
31 août, dimanche